Related references
Note: Only part of the references are listed.Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis
Koen Demyttenaere et al.
CNS DRUGS (2019)
Antipsychotic-induced tardive dyskinesia: update on epidemiology and management
Christian G. Widschwendter et al.
CURRENT OPINION IN PSYCHIATRY (2019)
Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States
Anita M. Loughlin et al.
PLOS ONE (2019)
Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort
David Misdrahi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2019)
Prevalence and pattern of antipsychotic induced movement disorders in a tertiary care teaching hospital in India - a cross-sectional study
Nimisha Desai et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2018)
Antipsychotic Drug-Induced Movement Disorders: A Forgotten Problem?
Tamara Pringsheim et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2018)
Neurological Soft Signs, Spontaneous and Treatment Emergent Extrapyramidal Syndromes in Black Africans With First Episode Schizophrenia.
Akin Ojagbemi et al.
FRONTIERS IN PSYCHIATRY (2018)
Management of common adverse effects of antipsychotic medications
T. Scott Stroup et al.
WORLD PSYCHIATRY (2018)
Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive DyskinesiaKey Differences in Pathophysiology and Clinical Management
Kristen M. Ward et al.
NEUROLOGY AND THERAPY (2018)
Effect of Antipsychotic Type and Dose Changes on Tardive Dyskinesia and Parkinsonism Severity in Patients With a Serious Mental Illness: The Curacao Extrapyramidal Syndromes Study XII
Charlotte L. Mentzel et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Antipsychotics-Induced Tardive Syndrome: A Retrospective Epidemiological Study
Min-Jing Lee et al.
CLINICAL NEUROPHARMACOLOGY (2014)
Second-generation antipsychotics in major depressive disorder: update and clinical perspective
Jun Chen et al.
CURRENT OPINION IN PSYCHIATRY (2011)
Movement Disorders Induced by Antipsychotic Drugs: Implications of the CATIE Schizophrenia Trial
Stanley N. Caroff et al.
NEUROLOGIC CLINICS (2011)
The effects of psychopathology on subjective experience of side effects of antipsychotics in patients with schizophrenia
Samuel Suk-Hyun Hwang et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
P03-12 Prevalence of extrapyramidal side effects in patients receiving depot antipsychotic medication
B. Luft et al.
EUROPEAN PSYCHIATRY (2009)
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Stefan Leucht et al.
LANCET (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Tardive dyskinesia and new antipsychotics
Christoph U. Correll et al.
CURRENT OPINION IN PSYCHIATRY (2008)
Antipsychotic-induced extrapyramidal symptoms and their management
Praveen Dayalu et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation
Nikolaos A. Patsopoulos et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2008)
Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes:: a meta-analysis of pharmacogenetic interactions
P. R. Bakker et al.
MOLECULAR PSYCHIATRY (2008)
Augmentation with a second antipsychotic in patients with schizophrenia who partially respond to clozapine - A meta-analysis
Carol Paton et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment
Stefan Gebhardt et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2006)
Side effects of atypical antipsychotics: Extrapyramidal symptoms and the metabolic syndrome
Arshia A. Shirzadi et al.
HARVARD REVIEW OF PSYCHIATRY (2006)
Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort):: a population-based study
GK Wenning et al.
LANCET NEUROLOGY (2005)
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies
CU Correll et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients
S Janno et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Dopamine partial agonists - A new class of antipsychotic
JA Lieberman
CNS DRUGS (2004)
Prevalence of extrapyramidal syndromes in psychiatric inpatients and the relationship of clozapine treatment to tardive dyskinesia
J Modestin et al.
SCHIZOPHRENIA RESEARCH (2000)
Share Paper
